Bio-Techne Corp TECH:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/02/21 EST
375.44quote price arrow up+3.00 (+0.81%)
Volume
194,866
52 week range
155.17 - 414.99

...

Loading . . .

KEY STATS

  • Open376.25
  • Day High377.13
  • Day Low370.42
  • Prev Close375.44
  • 52 Week High414.99
  • 52 Week High Date02/16/21
  • 52 Week Low155.17
  • 52 Week Low Date03/23/20
  • Market Cap14.567B
  • Shares Out38.80M
  • 10 Day Average Volume0.19M
  • Dividend1.28
  • Dividend Yield0.34%
  • Beta1.10
  • 1 Year % Change89.96

RATIOS/PROFITABILITY

  • EPS (TTM)4.39
  • P/E (TTM)85.56
  • Fwd P/E (NTM)61.98
  • EBITDA (MRQ)275.844M
  • ROE (MRQ)12.29%
  • Revenue (MRQ)798.97M
  • Gross Margin (MRQ)66.59%
  • Net Margin (MRQ)21.88%
  • Debt To Equity (MRQ)15.21%

EVENTS

  • Earnings Date04/28/2021
  • Ex Div Date02/11/2021
  • Div Amount0.32
  • Split Date-
  • Split Factor-

Latest Bio-Techne Corp News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences reporting segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and reagents, to the biotechnology community. The Protein Sciences segment also provides an array of platforms...
Robert Baumgartner CPA
Chairman
Charles Kummeth
President
James Hippel
Chief Financial Officer
Address
614 McKinley Pl NE
Minneapolis, MN
55413-2610
United States